Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation

Journal of the American College of Cardiology

Volumn 37, Issue 3, 2001, Pages 839-846

  Walter, Dirk H ^a   Fichtlscherer, Stephan ^a   Sellwig, Marc ^a   Auch Schwelk, Wolfgang ^a   Schächinger, Volker ^a   Zeiher, Andreas M ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; FEMALE; HEART DEATH; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; TREATMENT OUTCOME;

AGED; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; STENTS;

EID: 0035281527     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)01193-1     Document Type: Article

References (26)

1. Atherosclerosis - An inflammatory disease
2. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction
3. Inflammation, pravastatin and the risk of coronary events after myocardial infarction in patients with average cholesterol levels
4. Production of C-reactive protein and risk of coronary events in stable and unstable angina
5. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina
6. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men
7. Novel inflammatory markers of coronary risk: Theory versus practice
8. C-reactive protein as a cardiovascular risk factor: More than an epiphenomenon?
9. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina
10. Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina
11. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty
12. Patterns and mechanisms of in-stent restenosis: A serial intravascular ultrasound study
13. Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis
14. Assessment of short-, medium- and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms
15. Adjunctive intracoronary infusion of antithrombin III during percutaneous transluminal coronary angioplasty: Results of a prospective, randomized trial
16. Intracoronary stenting and risk for major adverse cardiac events during the first month
17. Stent thrombosis: Closing in on the best preventive treatment
18. Procoagulant inflammatory responses of monocytes after direct balloon angioplasty in acute myocardial infarction
19. Serum levels of circulating adhesion molecules after coronary angioplasty
20. Association of heparin-resistant thrombin activity with acute ischemic complications of coronary interventions
21. Previous cytomegalovirus infection and risk of coronary thrombotic events after stent placement
22. Body mass index, diabetes and C-reactive protein among U.S. adults
23. In-stent restenosis: Contributions of inflammatory responses and arterial injury to neointimal hyperplasia
24. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease: Benestent study group
25. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease: Stent restenosis study investigators
26. Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment